Safety, Tolerability and Prophylactic Antiviral Activity of Neumifil Against Influenza Via a Human Viral Challenge Model

NCT05507567 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

104

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza Viral Infections

Interventions

DRUG: Neumifil
DRUG: Placebo

Sponsor

Pneumagen Ltd.